| Isabel Balbin Nieveras, RN, BSN, MSN | |
|
350 N Sabana Barrigada Dr, Barrigada, GU 96913-1262 | |
| (671) 632-9370 | |
| (671) 632-1679 |
| Full Name | Isabel Balbin Nieveras |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 350 N Sabana Barrigada Dr, Barrigada, Guam |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982191227 | NPI | - | NPPES |
| 1228050369 | Other | GU | MEDICALLY INDIGENT PROGRAM (MIP) |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R1220 (Guam) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Isabel Balbin Nieveras, RN, BSN, MSN 350 N Sabana Barrigada Dr, Barrigada, GU 96913-1262 Ph: (671) 632-9370 | Isabel Balbin Nieveras, RN, BSN, MSN 350 N Sabana Barrigada Dr, Barrigada, GU 96913-1262 Ph: (671) 632-9370 |
News Archive
Research from 19 European countries in this week's issue of THE LANCET documents how childhood cancer, while still rare, has been slowly increasing over the past 3 decades.
A research team at the Greenwood Genetic Center (GGC) has identified the mechanism that causes movement disorders in patients with mutations in the NUS1 gene.
Most Americans make New Years' resolutions focused on wellness, and rightfully so - new research shows Americans have a long way to go toward achieving wellness based on the three pillars of health: healthy diet, responsible supplement use and regular exercise.
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today the publication of research from the labs of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and colleagues entitled, "Identification of a Novel Class of HCV Inhibitors". Published in the January 20th edition of Science and Translational Medicine, the research validates a domain, termed 4BAH2, within the non-structural protein (NS4B) of the HCV genome, as essential for HCV replication and describes the development of a high-throughput screen leading to the identification of small molecule inhibitors of 4BAH2.
Forget counting calories. The next new diet trend could be as simple as counting bites. A new study from BYU health science researchers found people who counted bites over a month's time lost roughly four pounds-just about what the CDC recommends for "healthy" weight loss.
› Verified 3 days ago
Mr. Brian R Moylan, BSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 988 Army Dr., Ste. 4, Barrigada, GU 96913 Phone: 671-475-4005 Fax: 671-475-4006 |